Antisense oligonucleotides provide optimism to the therapeutic landscape for tauopathies

被引：0
|
作者：
Glenn A.Harris [1 ]
Lauren R.Hirschfeld [1 ]
机构：
[1] Rainwater Charitable Foundation
来源：
Neural Regeneration Research | 2025年 / 20卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R741 [神经病学];
学科分类号：
1002 ;
摘要：
Tauopathies are a group of neurodegenerative diseases characterized by abnormal metabolism of the misfolded tau protein. Tau is encoded by the microtubule-associated protein tau gene(MAPT) and can be classified as either 3-repeat(3R) or 4-repeat(4R) based on the number of repeat domains from alternative splicing of exon 10 of the MAPT gene.
引用
收藏
页码：803 / 804
页数：2
相关论文
共 50 条
  • [31] Antisense oligonucleotides
    Offensperger, WB
    Thoma, C
    Hasselblatt, P
    Blum, HE
    STATE OF THE ART HEPATOLOGY: MOLECULAR AND CELL BIOLOGY: IN HONOUR OF HANS POPPER'S 100TH BIRTHDAY, 2004, 138 : 202 - 209
  • [32] Antisense oligonucleotides
    Scoles, Daniel R.
    Minikel, Eric V.
    Pulst, Stefan M.
    NEUROLOGY-GENETICS, 2019, 5 (02)
  • [33] Antisense oligonucleotides
    Kashihara, N
    Maeshima, Y
    Makino, H
    EXPERIMENTAL NEPHROLOGY, 1998, 6 (01): : 84 - 88
  • [34] ANTISENSE OLIGONUCLEOTIDES
    DEMESMAEKER, A
    HANER, R
    MARTIN, P
    MOSER, HE
    ACCOUNTS OF CHEMICAL RESEARCH, 1995, 28 (09) : 366 - 374
  • [35] ANTISENSE OLIGONUCLEOTIDES - FROM TOOLS IN MOLECULAR-GENETICS TO THERAPEUTIC AGENTS
    TOULME, JJ
    VERSPIEREN, P
    BOIZIAU, C
    LOREAU, N
    CAZENAVE, C
    THUONG, NT
    ANNALES DE PARASITOLOGIE HUMAINE ET COMPAREE, 1990, 65 : 11 - 14
  • [36] Antisense and therapeutic oligonucleotides: toward a gene-targeting cancer clinic
    Cho-Chung, YS
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (11) : 1711 - 1724
  • [37] Antisense oligonucleotides as a targeted therapeutic approach in model of acute myeloid leukemia
    Maceckova, Diana
    Vankova, Lenka
    Bufka, Jiri
    Hosek, Petr
    Moravec, Jiri
    Pitule, Pavel
    MOLECULAR BIOLOGY REPORTS, 2025, 52 (01)
  • [38] Adhesion molecules as targets for novel therapeutic approaches using antisense oligonucleotides
    Kronenwett, R
    Haas, R
    HIGH-DOSE THERAPY AND TRANSPLANTATION OF HAEMATOPOIETIC STEM CELLS, 2000, : 132 - 139
  • [39] RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
    Bennett, C. Frank
    Swayze, Eric E.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2010, 50 : 259 - 293
  • [40] Patent review: Therapeutic applications for antisense oligonucleotides 1999-2000
    Orr, RM
    O'Neill, CF
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2000, 2 (03) : 325 - 331
12345